The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication

被引:503
作者
Kessler, RC
Chiu, WT
Jin, R
Ruscio, AM
Shear, K
Walters, EE
机构
[1] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA
[2] Western Psychiat Inst & Clin, Pittsburgh, PA USA
关键词
D O I
10.1001/archpsyc.63.4.415
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Context: Only limited information exists about the epidemiology of DSM-IV panic attacks (PAs) and panic disorder (PD). Objective: To present nationally representative data about the epidemiology of PAs and PD with or without agoraphobia (AG) on the basis of the US National Comorbidity Survey Replication findings. Design and Setting: Nationally representative face-to-face household survey conducted using the fully structured World Health Organization Composite International Diagnostic Interview. Participants: English-speaking respondents ( N = 9282) 18 years or older. Main Outcome Measures: Respondents who met DSM-IV lifetime criteria for PAs and PD with and without AG. Results: Lifetime prevalence estimates are 22.7% for isolated panic without AG ( PA only), 0.8% for PA with AG without PD (PA-AG), 3.7% for PD without AG ( PD only), and 1.1% for PD with AG (PD-AG). Persistence, lifetime number of attacks, and number of years with attacks increase monotonically across these 4 subgroups. All 4 subgroups are significantly comorbid with other lifetime DSM-IV disorders, with the highest odds for PD-AG and the lowest for PA only. Scores on the Panic Disorder Severity Scale are also highest for PD-AG (86.3% moderate or severe) and lowest for PA only (6.7% moderate or severe). Agoraphobia is associated with substantial severity, impairment, and comorbidity. Lifetime treatment is high ( from 96.1% for PD-AG to 61.1% for PA only), but 12-month treatment meeting published treatment guidelines is low ( from 54.9% for PD-AG to 18.2% for PA only). Conclusion: Although the major societal burden of panic is caused by PD and PA-AG, isolated PAs also have high prevalence and meaningful role impairment.
引用
收藏
页码:415 / 424
页数:10
相关论文
共 54 条
[1]  
Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P28
[2]  
*AM PSYCH ASS, 1998, PRACT GUID TREATM PA
[3]  
[Anonymous], PROF SOFTW SURV DAT
[4]   Evidence-based pharmacotherapy of panic disorder [J].
Bakker, A ;
van Balkom, AJLM ;
Stein, DJ .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2005, 8 (03) :473-482
[5]   THE PHENOMENON OF PANIC [J].
BARLOW, DH ;
VERMILYEA, J ;
BLANCHARD, EB ;
VERMILYEA, BB ;
DINARDO, PA ;
CERNY, JA .
JOURNAL OF ABNORMAL PSYCHOLOGY, 1985, 94 (03) :320-328
[6]   A modern learning theory perspective on the etiology of panic disorder [J].
Bouton, ME ;
Mineka, S ;
Barlow, DH .
PSYCHOLOGICAL REVIEW, 2001, 108 (01) :4-32
[7]  
BURKE KC, 1990, ARCH GEN PSYCHIAT, V47, P511
[8]   A COGNITIVE APPROACH TO PANIC [J].
CLARK, DM .
BEHAVIOUR RESEARCH AND THERAPY, 1986, 24 (04) :461-470
[10]   A REVIEW OF THE RELATIONSHIP BETWEEN PANIC AND AVOIDANCE [J].
CRASKE, MG ;
BARLOW, DH .
CLINICAL PSYCHOLOGY REVIEW, 1988, 8 (06) :667-685